177 related articles for article (PubMed ID: 15662845)
21. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
22. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
Warncke T; Stubhaug A; Jørum E
Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
[TBL] [Abstract][Full Text] [Related]
23. Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
Kratzer U; Schmidt WJ
Neurosci Lett; 2003 Oct; 349(2):91-4. PubMed ID: 12946560
[TBL] [Abstract][Full Text] [Related]
24. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
25. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
[TBL] [Abstract][Full Text] [Related]
26. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory.
Li YQ; Xue YX; He YY; Li FQ; Xue LF; Xu CM; Sacktor TC; Shaham Y; Lu L
J Neurosci; 2011 Apr; 31(14):5436-46. PubMed ID: 21471379
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
29. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
[TBL] [Abstract][Full Text] [Related]
30. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
[TBL] [Abstract][Full Text] [Related]
31. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
Pinelli A; Trivulzio S; Spezia R
Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
33. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
Rasmussen K
Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
[TBL] [Abstract][Full Text] [Related]
34. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of mGluR2/3 receptors during morphine withdrawal in rats impairs mGluR2/3- and NMDA receptor-dependent long-term depression in the nucleus accumbens.
Qian Z; Wu X; Qiao Y; Shi M; Liu Z; Ren W; Han J; Zheng Q
Neurosci Lett; 2019 Jan; 690():76-82. PubMed ID: 30315852
[TBL] [Abstract][Full Text] [Related]
36. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
Kratzer U; Schmidt WJ
Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357
[TBL] [Abstract][Full Text] [Related]
37. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
Funada M; Schutz CG; Shippenberg TS
Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal.
Anderson EM; Reeves T; Kapernaros K; Neubert JK; Caudle RM
J Pharmacol Exp Ther; 2015 Dec; 355(3):496-505. PubMed ID: 26377910
[TBL] [Abstract][Full Text] [Related]
39. Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex.
Rada PV; Mark GP; Taylor KM; Hoebel BG
Pharmacol Biochem Behav; 1996 Apr; 53(4):809-16. PubMed ID: 8801582
[TBL] [Abstract][Full Text] [Related]
40. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
